H3 Biomedicine
Trending Articles
Related Content
Research & Development
Eisai, BMS and H3 Biomedicine announce research collaboration
Bristol-Myers Squibb, Eisai and its US-based precision medicine research and development subsidiary H3 Biomedicine, have announced a multiyear research collaboration focused on evaluating whether novel therapeutics leveraging H3's RNA splicing platform can provide a more powerful response against cancer